SCHEMBL6258338

SCHEMBL6258338

COc1ccc(CCC(O)CN2C[CH]N(Cc3ccc(Cl)c(Cl)c3)CC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 5/20 0.47
CACNA1G O43497 3/20 0.47
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
CYP2D6 P10635 1/20 0.42
LMNA P02545 2/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
MMP1 P03956 1/20 0.40
MMP9 P14780 1/20 0.40
MMP13 P45452 1/20 0.40
ADAM17 P78536 1/20 0.40
HRH1 P35367 1/20 0.39
CCR3 P51677 1/20 0.39
SIGMAR1 Q99720 5/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MCHR1 Q99705 1/20 0.39
ATM Q13315 1/20 0.38
MAPT P10636 1/20 0.38
TMEM97 Q5BJF2 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5226751 0.90 CYP2D6 (0.54) KCNH2CACNA1GCYP2D6LMNAMAPK1
SCHEMBL6261178 0.85 MEN1 (0.47) KCNH2CACNA1GMEN1KMT2ACYP2D6
SCHEMBL6186218 0.82 CACNA1G (0.52) KCNH2CACNA1GMEN1KMT2ALMNA
SCHEMBL6188797 0.79 CYP2D6 (0.55) KCNH2CACNA1GMEN1KMT2ACYP2D6
SCHEMBL4487892 0.76 LMNA (0.53) MEN1KMT2ACYP2D6LMNASMN1; SMN2
SCHEMBL5223079 0.75 CYP2D6 (0.48) KCNH2CACNA1GMEN1KMT2ACYP2D6
SCHEMBL6259368 0.73 SLC18A2 (0.43) MEN1KMT2ACYP2D6LMNAMAPK1
SCHEMBL5227165 0.73 CACNA1G (0.57) KCNH2CACNA1GMEN1KMT2ALMNA
SCHEMBL5224603 0.72
SCHEMBL6256508 0.72 KMT2A (0.44) MEN1KMT2ACYP2D6LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1578737-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS CV THERAPEUTICS, INC. (US) 2005-09-28 EP disclosed
WO-2004063180-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS CV THERAPEUTICS, INC. (US) 2004-07-29 WO disclosed